+86-13524779951 sales@xmobio.com
Products
  BIOACTIVE COMPOUND
  Anti-tumor series
  Antithrombotic series
  Anti-HCV series
  Rheumatism series
  Anti-diabetic series
  Nervous system series
  Others
  intermediate
  Featured products
  Others

This product is in stock,please ask for price.
If you have any question, please send the email to sales@xmobio.com for the availability.We will reply to you as soon as possible.
Shipment: Products are shipped via FedEx Express.
Products
Description
NX-2127 是一种口服有效的 BTK 抑制剂,可诱导细胞中突变的 BTKC481S 降解。NX-2127 抑制 BTKC481S 突变体 TMD8 细胞的增殖,比 Ibrutinib (HY-10997) 更有效。NX-2127 催化 Ikaros (IKZF1) 和 Aiolos (IKZF3) 的降解,对应的作用浓度分别为 25 nM 和 54 nM。NX-2127 刺激 T 细胞活化并增加原代人 T 细胞中 IL-2 的产生。 
Chemical Structure
 
Chemical Name
2-Pyrazinecarboxamide, 3-[[4-[1-[[(3S)-1-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-5-yl]-3-pyrrolidinyl]methyl]-4-piperidinyl]phenyl]amino]-5-(1-piperidinyl)- 
Theoretical Analysis
XingMo Cat#:XM817 
Product Name:NX227 
Synonyms:NX-2127 
CAS#:2416131-46-7 
Chemical Formula:C39H45N9O5 
Exact Mass:719.83 
Molecular Weight:719.83 
Purity:98% 
Technical Data

Solubility: Soluble in DMSO, not in water

Shelf Life:

>2 years if stored properly.

Drug Formulation:

This drug may be formulated in DMSO

Stock Solution Storage:

0 - 4 ℃ for short term (days to weeks), or -20 ℃ for long term (months).

 



WARNING: This product is for research use only, not for human or veterinary use

Tel: +8613524779951  QQ: 点击这里给我发消息
Email: sales@xmobio.com   Web: www.xmobio.com  沪ICP备17047952号-1
Copyright 2017 Shanghai xingMo Biotechnology Co., Ltd. All rights reserved. Supported by www.hxchem.net